Bath & Body Works’ (BBWI) Outperform Rating Reiterated at Telsey Advisory Group

Telsey Advisory Group restated their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research report released on Monday morning,Benzinga reports. They currently have a $42.00 target price on the stock.

Several other equities analysts also recently commented on the stock. The Goldman Sachs Group lowered their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Barclays cut Bath & Body Works from an “equal weight” rating to an “underweight” rating and dropped their price objective for the stock from $31.00 to $28.00 in a report on Friday, November 8th. Evercore ISI reduced their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 28th. BMO Capital Markets reaffirmed an “outperform” rating and issued a $50.00 price target (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Finally, Wells Fargo & Company reduced their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $42.44.

Bath & Body Works Price Performance

BBWI opened at $30.52 on Monday. The stock’s 50 day simple moving average is $30.41 and its 200 day simple moving average is $36.14. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The firm has a market cap of $6.69 billion, a price-to-earnings ratio of 7.39, a PEG ratio of 1.00 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. As a group, sell-side analysts anticipate that Bath & Body Works will post 3.18 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.62%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 19.37%.

Insider Transactions at Bath & Body Works

In other news, CEO Gina Boswell purchased 6,000 shares of the business’s stock in a transaction dated Wednesday, October 9th. The shares were purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Bath & Body Works

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Anomaly Capital Management LP bought a new stake in shares of Bath & Body Works in the 2nd quarter worth $113,995,000. FMR LLC increased its holdings in Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after buying an additional 2,501,828 shares in the last quarter. KBC Group NV raised its position in Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares during the last quarter. Erste Asset Management GmbH bought a new position in Bath & Body Works during the 3rd quarter valued at about $50,483,000. Finally, Lone Pine Capital LLC lifted its stake in Bath & Body Works by 15.8% during the 2nd quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after acquiring an additional 1,547,399 shares during the period. 95.14% of the stock is owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.